Drug: dexamethasone Quarter: 2016Q3
Total Records: 1,559 Number of Pages: 78
| DRUGNAME | PT | EventCount |
|---|---|---|
| DEXAMETHASONE SALT NOT SPECIFIED | Lymphadenopathy | 1 |
| DEXAMETHASONE SALT NOT SPECIFIED | Malignant neoplasm progression | 1 |
| DEXAMETHASONE SALT NOT SPECIFIED | Meningitis tuberculous | 1 |
| DEXAMETHASONE SALT NOT SPECIFIED | Multiple-drug resistance | 1 |
| DEXAMETHASONE SALT NOT SPECIFIED | Pathogen resistance | 1 |
| DEXAMETHASONE SALT NOT SPECIFIED | Pupils unequal | 1 |
| DEXAMETHASONE SALT NOT SPECIFIED | Pyrexia | 1 |
| DEXAMETHASONE SALT NOT SPECIFIED | T-cell lymphoma | 1 |
| DEXAMETHASONE SALT NOT SPECIFIED | Treatment failure | 1 |
| Dexamethasone Sodium Phosphate (Watson Laboratories) | Tumour lysis syndrome | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP | Confusional state | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP | Headache | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP | Pyrexia | 1 |
| Dexamethasone Sodium Phosphate Injection, USP (4901-25) | Aspergillus infection | 1 |
| Dexamethasone Sodium Phosphate Injection, USP (4901-25) | Exposure during pregnancy | 1 |
| Dexamethasone Sodium Phosphate Injection, USP (4901-25) | Osteonecrosis | 1 |
| Dexamethasone Sodium Phosphate Injection, USP (4901-25) | Seizure | 1 |
| Dexamethasone Sodium Phosphate Injection, USP (4901-25) | Vanishing bile duct syndrome | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE OPHTHALMIC SOLUTION USP 0.1% | Anxiety | 1 |
| DEXAMETHASONE SODIUM PHOSPHATE OPHTHALMIC SOLUTION USP 0.1% | Eye disorder | 1 |
Total Records: 1,559 Number of Pages: 78